Genprex (GNPX) Preferred Shares (2016 - 2017)
Genprex (GNPX) posted quarterly Preferred Shares of $1.0 for Q3 2017, down 99.9% quarter-over-quarter from $1002.0 in Q4 2016.
Genprex (GNPX) Preferred Shares (2016 - 2017) Analysis & Trends
Genprex's Preferred Shares history runs 2 years deep, the most recent figure standing at $1.0 for Q3 2017.
- In Q3 2017, Preferred Shares changed N/A year-over-year to $1.0; the TTM figure through Sep 2017 stood at $1.0 (changed N/A YoY), while the FY2016 annual figure was $1002.0, changed N/A from the prior year.
- Preferred Shares for Q3 2017 stood at $1.0, down from $1002.0 in the prior quarter.
- The five-year high for Preferred Shares was $1002.0 in Q4 2016, with the low at $1.0 in Q3 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Genprex | 1.88 Mn | -13.28 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2017 | 1.00 |
| Dec 31, 2016 | 1,002.00 |